Quantcast
Channel: BIOtechNow » BTK
Browsing latest articles
Browse All 6 View Live

Image may be NSFW.
Clik here to view.

2009 – A Big Year for the BTK

The Amex Biotech Index, the BTK, outpaced its peer, the Nasdaq Biotech Index, by 29% and was 22% above the SP500.   Most of this can be attributed to 3rd quarter performance when Human Genome Sciences...

View Article



Image may be NSFW.
Clik here to view.

BTK – A Decade of Change

Do you ever wonder what is really behind the often quoted BTK index (“NYSE Arca Biotechnology Index”)? Especially if it is the index you compare your own company’s stock with on a long term chart? If...

View Article

Image may be NSFW.
Clik here to view.

1Q 2010 – All Time High for the BTK

The first quarter of 2010 saw the Amex Biotech Index (BTK) hit another all time high, thanks largely to Intermune’s (ITMN) jump of 240% and OSI’s (OSIP) gain of 92%. (Intermune received a positive...

View Article

Image may be NSFW.
Clik here to view.

Biotech Sector Performance Update 1H 2010

In my last update back in April, the broadest Biotech index (the 125 company Nasdaq Biotech Index, NBI) was up 11% for the year and ahead of just about every major sector. One quarter later things look...

View Article

Image may be NSFW.
Clik here to view.

The BTK buyout

Remember this BTK post we wrote back  in February of 2010?  Well, we thought it was time to revisit the makeup of the BTK index (NYSE Arca Biotechnology Index).  Five of  the 20 companies that...

View Article


Image may be NSFW.
Clik here to view.

A Very Big BTK January

We all heard reports that January was a great start to 2012 for the stock market, and even more so for Biotech. But how big was it, really? The Amex Biotech Index (the “BTK“) had its biggest January on...

View Article
Browsing latest articles
Browse All 6 View Live




Latest Images